Ligand Pharmaceuticals LGND Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's preferred stock, shares authorized?
- Ligand Pharmaceuticals (LGND) reported preferred stock, shares authorized of $5M in Q1 2026.
- How has Ligand Pharmaceuticals's preferred stock, shares authorized changed year-over-year?
- Ligand Pharmaceuticals's preferred stock, shares authorized decreased by 0.0% year-over-year, from $5M to $5M.
- What is the long-term trend for Ligand Pharmaceuticals's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $5M to $5M.